Both in Pharmaceuticals
Elanco Animal Health Incorporated vs Spyre Therapeutics
Over the past year ELAN returned +7.5% and SYRE returned +317.5%; their daily moves had a correlation of 0.14.
ELAN +7.5% SYRE +317.5%Growth of $1, one year, split-adjusted
| Metric | ELAN | SYRE |
|---|---|---|
| Price | $24.57 | $99.27 |
| Market cap | $12.28B | $9.28B |
| Today | +1.95% | +3.94% |
| 1 month | +9.2% | +7.1% |
| 6 months | +6.9% | +39.8% |
| Year to date | +8.6% | +203.0% |
| 1 year | +10.9% | +305.8% |
| Revenue growth (YoY) | +10.2% | — |
| Gross margin | 58.3% | — |
| Net margin | 3.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.4× | — |
| Net cash | -$3.39B | $1.15B |
| Dividend yield | — | — |
| Volatility (60d) | 30.4% | 59.2% |
| Short % of float | 6.3% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).